Detection, isolation, and analysis of single ctcs
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261201300034C
- Awardee
-
Pgxl Technologies LLC UEI ZFN5J433DCT1
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $299,654
Award facts
- Opportunity
-
- PHS20131 Solicitation number
- Solicitation of the national institutes of health and the centers for disease control and prevention for small business innovation research contract proposals Award Notice · Posted Nov 1, 2012
- A solicitation of the national institutes of health (NIH) and the centers for disease control and prevention (CDC) for small business innovation research (SBIR) contract proposals Award Notice · Posted Jul 30, 2012
- Contract value 100% obligated
- $299,654.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 23 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Louisville, KY 40202, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Change Order | $0 | |
| Original award | $299,654 |
About this award
This is a $299,654 firm fixed price contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Pgxl Technologies LLC, a minority-owned limited liability company. The contract, titled "DETECTION, ISOLATION, AND ANALYSIS OF SINGLE CTCS," has a completion date of September 12, 2014 and does not appear to have a set-aside designation. The contract is for the detection, isolation, and analysis of single circulating tumor cells (CTCs). Pgxl Technologies LLC is the prime contractor, and no subcontractors are mentioned. The contract award provides funding for this specific R&D effort within the NCI's broader cancer research mission.
Quick answers
Who was awarded contract HHSN261201300034C?
HHSN261201300034C was awarded to Pgxl Technologies LLC by National Cancer Institute (National Institutes of Health) on September 13, 2013.
How much is contract HHSN261201300034C worth?
The government has obligated $299,654 on HHSN261201300034C.
Was contract HHSN261201300034C competed?
The extent of competition for HHSN261201300034C was full and open competition. The government received 23 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award